UniSuper Management Pty Ltd raised its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 2.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 112,143 shares of the industrial products company's stock after acquiring an additional 2,296 shares during the quarter. UniSuper Management Pty Ltd's holdings in Xylem were worth $13,397,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also made changes to their positions in XYL. Schonfeld Strategic Advisors LLC boosted its position in shares of Xylem by 30.0% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 3,499 shares of the industrial products company's stock worth $406,000 after acquiring an additional 808 shares in the last quarter. D. E. Shaw & Co. Inc. boosted its position in shares of Xylem by 1,060.6% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 281,924 shares of the industrial products company's stock worth $32,709,000 after acquiring an additional 257,633 shares in the last quarter. Ensign Peak Advisors Inc boosted its position in shares of Xylem by 1.5% during the 4th quarter. Ensign Peak Advisors Inc now owns 95,331 shares of the industrial products company's stock worth $11,060,000 after acquiring an additional 1,418 shares in the last quarter. Gotham Asset Management LLC boosted its position in shares of Xylem by 72.4% during the 4th quarter. Gotham Asset Management LLC now owns 110,338 shares of the industrial products company's stock worth $12,801,000 after acquiring an additional 46,341 shares in the last quarter. Finally, Laird Norton Wetherby Wealth Management LLC boosted its position in shares of Xylem by 16.6% during the 4th quarter. Laird Norton Wetherby Wealth Management LLC now owns 26,332 shares of the industrial products company's stock worth $3,055,000 after acquiring an additional 3,757 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.
Xylem Stock Down 1.0%
Xylem stock opened at $140.52 on Monday. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $145.33. The stock has a 50 day moving average of $137.36 and a two-hundred day moving average of $127.20. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $34.20 billion, a price-to-earnings ratio of 36.50, a PEG ratio of 2.43 and a beta of 1.09.
Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The company had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.20 billion. During the same period last year, the firm earned $1.09 EPS. The firm's revenue for the quarter was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, research analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.
Xylem Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Thursday, August 28th. Xylem's dividend payout ratio (DPR) is currently 41.56%.
Analyst Ratings Changes
Several research firms have recently issued reports on XYL. TD Cowen upped their price objective on Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a research report on Tuesday, August 26th. Raymond James Financial raised Xylem to a "hold" rating in a research report on Thursday, May 15th. UBS Group upped their target price on Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a research report on Tuesday, August 5th. Cowen reissued a "hold" rating on shares of Xylem in a research report on Tuesday, August 26th. Finally, Stifel Nicolaus upped their target price on Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research report on Friday, August 1st. Six analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $152.29.
Read Our Latest Stock Analysis on Xylem
Insider Activity at Xylem
In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the sale, the chief accounting officer directly owned 2,957 shares of the company's stock, valued at $413,861.72. This trade represents a 25.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.27% of the stock is owned by corporate insiders.
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report